(Q44201200)

30 November 2017

title

Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures (English)

1 reference

30 November 2017

1 reference

David W Herd

5

0 references

Lubbe Wiesner

object named as

Lubbe Wiesner

4

0 references

Brian Anderson

2

object named as

Brian J Anderson

1 reference

30 November 2017

author name string

Katharine E J Brunette

1

1 reference

30 November 2017

Jennifer Thomas

3

1 reference

30 November 2017

Simone Schulein

6

1 reference

30 November 2017

publication date

28 February 2011

1 reference

30 November 2017

published in

Paediatric Anaesthesia

1 reference

30 November 2017

volume

21

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

653-662

1 reference

Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Ketamine is a safe, effective, and appropriate technique for emergency department paediatric procedural sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Anticholinergics and ketamine sedation in children: a secondary analysis of atropine versus glycopyrrolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Predictors of emesis and recovery agitation with emergency department ketamine sedation: an individual-patient data meta-analysis of 8,282 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Is atropine needed with ketamine sedation? A prospective, randomised, double blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Combination of oral ketamine and midazolam as a premedication for a severely autistic and combative patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Ketamine plus midazolam, a most effective paediatric oral premedicant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Lack of pharmacokinetic information in children leads clinicians to use experience and trial-and-error to determine how best to administer ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

A randomized, controlled trial of i.v. versus i.m. ketamine for sedation of pediatric patients receiving emergency department orthopedic procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Should I give ketamine i.v. or i.m.?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Modeling the norketamine metabolite in children and the implications for analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Ketamine kinetics in unmedicated and diazepam-premedicated subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Pharmacokinetics and analgesic effect of ketamine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Ketamine disposition in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Extensions to the visual predictive check to facilitate model performance evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Facilitation of drug evaluation in children by population methods and modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

The impact of admission diagnosis on gastric emptying in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Mechanisms of burn-induced impairment in gastric slow waves and emptying in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Can bioavailability of low-variance drugs be estimated with an unpaired, sparse sampling design?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Tips and traps analyzing pediatric PK data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Effects of norketamine enantiomers in rodent models of persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Scaling for size: some implications for paediatric anaesthesia dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Mechanism-based concepts of size and maturity in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

Mechanistic basis of using body size and maturation to predict clearance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2011.03548.X

10.1111/J.1460-9592.2011.03548.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference